Skip to content
Screener

Xencor XNCR Total Current Liabilities

Total Current Liabilities at other companies

Amgen logo
AmgenAMGN
$25.5B+24.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.53B+50.8%
Janux Therapeutics logo
Janux TherapeuticsJANX
$60.15M+181%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$53.19M-20.6%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$41.7M-5.3%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$10.54M+13.2%

Other financials

Income statement

See full
Revenue$51.2M+17.5%
Operating income-$37.1M-11.7%
Net income-$21.7M+29.5%
EPS (diluted)-$0.29+29.3%

Balance sheet

See full
Cash & equivalents$44.7M+0.5%
Total debt$170.1M-20.1%
Total equity$503.2M-18.9%
Total assets$725.0M-17.6%

Cash flow

See full
Operating cash flow-$55.7M-53.0%
CapEx$538.0K+40.5%
Free cash flow-$56.2M-52.9%

Valuation

See full
Market cap$1.55B+210%
Enterprise value$1.67B+150%
P/S14.7×+11.3×

Profitability

See full
Operating margin-205.8%-2,501pp
Net margin-155.6%+78.8pp
FCF margin-198.4%-1,485pp

Returns & leverage

See full
Return on equity-29.1%+0.2pp
Debt / equity0.3×0.0×
Current ratio6.4×+1.1×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Xencor’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:02 PM EDT
Fiscal quarter
Q4 FY2028
Calendar quarter
Q4 2028
Accession
0001326732-26-000056
Line itemJune 30,2026December 31,2025
Income tax payable1,4963,589
Lease liabilities3,9173,263
Liabilities related to the sales of future royalties27,35843,267
Total current liabilities81,86595,907
Long-term tax liabilities8832,784
Lease liabilities, net of current portion61,29564,735
Liabilities related to the sales of future royalties, net of current portion77,53776,482
Other liabilities152

Item 1. Financial Statements

FAQ

What is Xencor's total current liabilities?
Xencor (XNCR) reported total current liabilities of $81.87M in Q2 2026.
How has Xencor's total current liabilities changed year-over-year?
Xencor's total current liabilities decreased by 14.8% year-over-year, from $96.08M to $81.87M.
What is the long-term trend for Xencor's total current liabilities?
Over 5 years (2020 to 2025), Xencor's total current liabilities has grown at a -4.6% compound annual growth rate (CAGR), from $121.06M to $95.91M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Xencor's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude